Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Aktis Oncology is 43 — signals are mixed heading into the print. Underlying trend: 2 of 3 tracked signals trending up over the last 3 months.
Aktis Oncology (AKTS) is trading at $24.10, up 23.4% over the last 3 months (from $19.53 three months ago).
Trends across the last 3 months — the run-up to Aktis Oncology’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 4 | ↓ -20.0% |
| LinkedIn headcount | 103 | ↑ +14.4% |
| Web traffic | 9,457 | ↑ +106.9% |
Full daily-resolution trend charts on every signal are on the AKTS ticker page.
AltIndex stock alerts fire when alt-data on AKTS breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Aktis Oncology — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in